Posts

Showing posts with the label Gastroretentive Drug Delivery Systems Market 2028

Gastroretentive Drug Delivery Systems Market Estimated At USD 19.7 Billion By 2028

Image
  San Francisco, 20 Dec 2021:   The Report  Gastroretentive Drug Delivery Systems Market  Size, Share & Trends Analysis Report By Type (Tablets, Liquid, Capsule), By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2021 - 2028 The global gastroretentive drug delivery systems market size is estimated to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period. Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the

Gastroretentive Drug Delivery Systems Market Size To Hit USD 19.7 Billion By 2028

  San Francisco, 17 May 2021:   The Report  Gastroretentive Drug Delivery Systems Market  Size, Share & Trends Analysis Report By Type (Tablets, Liquid, Capsule), By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2021 - 2028 The global gastroretentive drug delivery systems market size is estimated to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period. Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the